Interplay between host and pathogen: immune defense and beyond

Interplay between host and pathogen: immune defense and beyond


Play all audios:


Download PDF Editorial Open access Published: 11 December 2019 Interplay between host and pathogen: immune defense and beyond Eun-Kyeong Jo  ORCID: orcid.org/0000-0001-7191-05871,2 


Experimental & Molecular Medicine volume 51, pages 1–3 (2019)Cite this article


13k Accesses


57 Citations


3 Altmetric


Metrics details


Host–pathogen interaction is considered a highly dynamic process between diverse microbial pathogens and hosts in all stages of pathogenic infection, from invasion to dissemination. Upon


pathogenic infection, innate immune systems respond to pathogen-associated molecular patterns and activate immediate host inflammatory and antimicrobial responses1,2. Innate immune cells


trigger sophisticated intracellular signaling pathways via innate immune receptors, including membrane-bound or cytosolic receptors1,2,3. Host innate immune activation results in the


production of multiple effector molecules, including cytokines and chemokines as well as antimicrobial proteins, to combat invading pathogens and parasites4. In addition, innate immune


cells, such as macrophages and dendritic cells, are the principal antigen-presenting cells that activate T cells, which are involved in more specific and delicate immune responses5,6. In


particular, Th1 cell-mediated interferon (IFN)-γ can efficiently promote cell-autonomous host defenses against intracellular parasitic and mycobacterial infections through various effectors,


including IFN-inducible GTPases, inducible nitric oxide synthase, and autophagy proteins7,8.


Here, a special issue of articles presents recent findings on how host immune and pathological responses are generated by intracellular signaling machinery, which can be activated at various


stages of host–pathogen interaction, and further describes how pathogens subvert host protective responses to establish an infection in the harsh environment inside host cells. In addition,


this special issue includes invited reviews that discuss current knowledge of host defensive components and pathways, i.e., immune receptors, cytokines, signaling molecules, autophagy, and


the microbiota. We further describe recent innovative trials based on studies of the host–pathogen interface involving the therapeutic utilization of bacteria in the context of anticancer


treatments. A comprehensive understanding of host–pathogen interaction will provide new insights into the identification of novel targets for both host effectors and microbial factors and


will lead to new therapeutic treatments for infections and other human diseases.


When encountering the host defense system, numerous intracellular pathogens employ a variety of evolved strategies to escape, modulate, and hijack host immunity during infection9. Lee and


coworkers provide a comprehensive summary of viral strategies that evade host cytosolic sensing to facilitate intracellular infection and replication of viruses. Although innate immune


responses are essential for combating viral infections, they should be tightly regulated to prevent harmful host responses. Lee and coworkers also review recent findings on the positive and


negative regulatory mechanisms for intracellular sensors in-host cells. Recent studies have uncovered key signaling molecules that participate in the recognition of cytosolic


pathogen-associated molecular patterns (PAMPs) and the activation of innate immune responses against viral infection10,11. Ahn and Barber highlight the immune regulatory functions of


stimulators of interferon genes and cyclic dinucleotides that can recognize microbial DNA from various pathogens, including bacteria, viruses, and parasites, as well as cytosolic DNA of


self-origin from host cells. Investigations on the abundance of in-host effector mechanisms and pathogenic strategies will provide an ideal opportunity to develop innovative tools that can


be utilized to modulate microbial pathogenesis.


Autophagy, a cell-autonomous catabolic pathway involving lysosomal degradation of cargos, is becoming recognized as an innate effector mechanism to enhance pathogen control and resolution of


tissue pathology associated with infection12,13,14. Jo and coworkers summarize the function of autophagy and xenophagy in mycobacterial infection and how to manipulate autophagy pathways to


promote host-targeted therapeutics against mycobacterial infection. A more comprehensive understanding of the elaborate mechanisms by which host autophagy pathways overcome bacterial


pathogenesis strategies may lead to more efficient antimicrobial defense strategies against numerous intracellular pathogens that can reside and replicate within the host cell


cytoplasm14,15,16.


When considering the role of type I and II interferons (IFNs) in the activation of antiviral and Th1 immune responses, respectively, it is generally accepted that IFN actions are typically


required for protective immune responses against viruses and intracellular bacteria. Yamamoto and Sasai discuss recent progress on the cell-intrinsic defense mechanisms by which


IFN-inducible GTPase-dependent host defenses exhibit antiparasitic and antibacterial responses. IFN-γ-inducible GTPases, including guanylate binding proteins (GBPs) and immunity-related


GTPases (IRGs), are essential in various aspects of immune protective functions, including the release of bacterial components, production of reactive nitrogen species, inflammasome


activation, and autophagy7,8,17,18. Recent studies have also revealed the function of cytokines, including type I IFNs, IL-15, and IL-18, in the bystander activation of CD8 + T cells, which


are responsible for tissue injury in viral infections19,20. Shin and Kim will present a new concept of bystander response, which leads to pathological or protective outcomes, depending on


the context. An understanding of the IFN-inducible responses in various aspects of host–pathogen interactions will be essential for the development of effective therapeutics that also


minimize tissue damage.


Accumulating evidence supports the importance of the gut microbiota in human health and diseases. Takeda and Maeda summarize the recent findings of molecular details in-host-microbe


interactions in rheumatoid arthritis and how alterations at the interface between the host and microbes result in excessive inflammation and infection. In addition, this review will


introduce multiple metabolic and immunological mechanisms by which the gut and oral microbiota induce the development of arthritis21. To date, the majority of studies on host–pathogen


interactions have focused on comprehensive elucidation of the innate and adaptive immune responses during infection. Recently, several efforts have been made to manipulate genetically


modified bacteria for utilization as a new form of therapeutic agent for the treatment of cancer22. Min and coworkers review the current trials, perspectives, and limitations of therapeutic


approaches using live bacteria with tumor-targeting ability and discuss recent advances in our understanding of bacterium-tumor cell interactions.


In revealing a vast array of strategies adopted by host cells and pathogens during various stages of infection, paradigms are shifting. Accumulating evidence indicates a more diverse impact


of pathogenic manipulations of host cells than previously known. This special issue highlights recent advances in studies that extend traditional concepts of host–pathogen interactions


toward new insights on innate and adaptive immune signaling, molecular pathogenesis, host-directed therapy, and manipulation of bacteria for anticancer therapy. We believe that the


cutting-edge reviews presented here will provide novel insights into the growing area of host–pathogen interface signaling, thereby expanding basic knowledge for use in clinical


applications. Studying the basic and applied fields relating to this topic will promote our knowledge of highly complex host–pathogen relationships and facilitate future investigations in


this area for the development of improved therapies against infections.


References Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257–263 (2004).


Article  CAS  Google Scholar 


Meylan, E., Tschopp, J. & Karin, M. Intracellular pattern recognition receptors in the host response. Nature 442, 39–44 (2006).


Article  CAS  Google Scholar 


Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).


Article  CAS  Google Scholar 


Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373–384 (2010).


Article  CAS  Google Scholar 


Deenick, E. K., Ma, C. S., Brink, R. & Tangye, S. G. Regulation of T follicular helper cell formation and function by antigen presenting cells. Curr. Opin. Immunol. 23, 111–118 (2011).


Article  CAS  Google Scholar 


Breed, E. R., Lee, S. T. & Hogquist, K. A. Directing T cell fate: how thymic antigen presenting cells coordinate thymocyte selection. Semin. Cell Dev. Biol. 84, 2–10 (2018).


Article  CAS  Google Scholar 


Sasai, M., Pradipta, A. & Yamamoto, M. Host immune responses to Toxoplasma gondii. Int. Immunol. 30, 113–119 (2018).


Article  CAS  Google Scholar 


Sasai, M. et al. Essential role for GABARAP autophagy proteins in interferon-inducible GTPase-mediated host defense. Nat. Immunol. 18, 899–910 (2017).


Article  CAS  Google Scholar 


Hajishengallis, G. & Lambris, J. D. Microbial manipulation of receptor crosstalk in innate immunity. Nat. Rev. Immunol. 11, 187–200 (2011).


Article  CAS  Google Scholar 


Chow, K. T., Gale, M. Jr. & Loo, Y. M. RIG-I and other RNA sensors in antiviral immunity. Annu. Rev. Immunol. 36, 667–694 (2018).


Article  CAS  Google Scholar 


Ma, Z., Ni, G. & Damania, B. Innate sensing of DNA virus genomes. Annu. Rev. Virol. 5, 341–362 (2018).


Article  CAS  Google Scholar 


Deretic, V. & Levine, B. Autophagy balances inflammation in innate immunity. Autophagy 14, 243–251 (2018).


Article  CAS  Google Scholar 


Deretic, V., Saitoh, T. & Akira, S. Autophagy in infection, inflammation and immunity. Nat. Rev. Immunol. 13, 722–737 (2013).


Article  CAS  Google Scholar 


Paik, S., Kim, J. K., Chung, C. & Jo, E. K. Autophagy: A new strategy for host-directed therapy of tuberculosis. Virulence 10, 448–459 (2019).


Article  CAS  Google Scholar 


Bah, A. & Vergne, I. Macrophage autophagy and bacterial infections. Front. Immunol. 8, 1483 (2017).


Article  Google Scholar 


Pareja, M. E. & Colombo, M. I. Autophagic clearance of bacterial pathogens: molecular recognition of intracellular microorganisms. Front. Cell Infect. Microbiol 3, 54 (2013).


PubMed  Google Scholar 


Meunier, E. & Broz, P. Interferon-inducible GTPases in cell autonomous and innate immunity. Cell Microbiol. 18, 168–180 (2016).


Article  CAS  Google Scholar 


Pilla-Moffett, D., Barber, M. F., Taylor, G. A. & Coers, J. Interferon-inducible GTPases in host resistance, inflammation and disease. J. Mol. Biol. 428, 3495–3513 (2016).


Article  CAS  Google Scholar 


Whiteside, S. K., Snook, J. P., Williams, M. A. & Weis, J. J. Bystander T cells: a balancing act of friends and foes. Trends Immunol. 39, 1021–1035 (2018).


Article  CAS  Google Scholar 


Kim, J. et al. Innate-like cytotoxic function of bystander-activated CD8(+) T cells is associated with liver injury in acute hepatitis A. Immunity 48, 161–173.e5 (2018).


Article  CAS  Google Scholar 


Maeda, Y. et al. Dysbiosis contributes to arthritis development via activation of autoreactive t cells in the intestine. Arthritis Rheuma. 68, 2646–2661 (2016).


Article  CAS  Google Scholar 


Kaimala, S., Al-Sbiei, A., Cabral-Marques, O., Fernandez-Cabezudo, M. J. & Al-Ramadi, B. K. Attenuated bacteria as immunotherapeutic tools for cancer treatment. Front. Oncol. 8, 136 (2018).


Article  Google Scholar 


Download references

Acknowledgements


This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP; Ministry of Science, ICT & Future Planning) (2017R1A5A2015385) and by


the framework of international cooperation program managed by NRF of Korea (Grant Number: 2015K2A2A6002008).


Author informationAuthors and Affiliations Department of Microbiology, Chungnam National University School of Medicine, Daejeon, 35015, Korea


Eun-Kyeong Jo


Department of Infection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, 35015, Korea


Eun-Kyeong Jo


AuthorsEun-Kyeong JoView author publications You can also search for this author inPubMed Google Scholar


Corresponding author Correspondence to Eun-Kyeong Jo.

Ethics declarationsConflict of interest


The author declares that she has no conflict of interest.

Additional information


Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions


Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or


format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or


other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in


the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the


copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.


Reprints and permissions


About this articleCite this article Jo, EK. Interplay between host and pathogen: immune defense and beyond. Exp Mol Med 51, 1–3 (2019). https://doi.org/10.1038/s12276-019-0281-8


Download citation


Received: 29 March 2019


Accepted: 19 April 2019


Published: 11 December 2019


Issue Date: December 2019


DOI: https://doi.org/10.1038/s12276-019-0281-8


Share this article Anyone you share the following link with will be able to read this content:


Get shareable link Sorry, a shareable link is not currently available for this article.


Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative


This article is cited by Glutathione reductase modulates endogenous oxidative stress and affects growth and virulence in Avibacterium paragallinarum Yan ZhiChen MeiHongjun Wang Veterinary


Research (2025)


A multi-epitope subunit vaccine providing broad cross-protection against diverse serotypes of Streptococcus suis Jianan LiuZhen ZhangJiale Ma npj Vaccines (2024)


Integrated Information for Pathogenicity and Treatment of Spiroplasma Yixue YouJianmin XiaoPeng Liu Current Microbiology (2024)


Exploring Liposomal Systems for Gallic Acid and Tannic Acid Delivery: Potential Strategies to Address Inflammation and Infections in Pediatric Ventricular Assist Device Recipients Yongjun


MaLanlan GuoYanyan Xu Journal of Pharmaceutical Innovation (2023)


Gut microbiota modulation induced by Zika virus infection in immunocompetent mice Rafael CorrêaIgor de Oliveira SantosKelly Grace Magalhães Scientific Reports (2021)